Clinical trial

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) Therapy

NCT07787260

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-01

PhasePHASE3

Study timeline

Study start (estimated)2026-08-01Date precision: month

Registry last updated2026-08-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obstructive Sleep Apnea (OSA) and Obesityunresolved

Interventions

HDM1005DRUG

PlaceboDRUG

Sponsors & collaborators

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07787260 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.